Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04853316 · ClinicalTrials.gov registry record
Asymptomatic SARS-CoV-2 Detection in Children
A clinical trial of Covid19 and SARS-CoV-2, sponsored by University of Calgary.
- Completed
- Registry status
- 372
- Enrollment target
- 5
- Study locations
NCT04853316 is a study of Covid19 and SARS-CoV-2 that has completed, run by University of Calgary. The registered enrollment target is 372 participants, below the 2,698-participant average among 94 other Covid19 trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT04853316, a study of Covid19 and SARS-CoV-2, has completed, sponsored by University of Calgary.
- COMPLETED
- Registry status
- 372 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary objective of this study is quantify the transmission risk posted by SARS-CoV-2 in pre/asymptomatic infected children in order to inform the public health response to the COVID-19 pandemic.
Conditions Studied
Study Locations (5)
Alabama
- Children's of Alabama - Birmingham
California
- University of California, San Diego - Rady Children's Hospital - San Diego
Massachusetts
- Boston Children's Hospital - Boston
Texas
- Children's Medical Center of Dallas - UT Southwestern - Dallas
Alberta
- Alberta Children's Hospital - Calgary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2021-01-31 |
| Est. Completion | 2022-08-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04853316
The ClinicalTrials.gov registry entry for NCT04853316 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 372 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,698-participant average among 94 other Covid19 trials with a reported enrollment target (86% lower). The listed sponsor is University of Calgary, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Covid19 appearing as the primary indexed condition, and to 0 interventions.
NCT04853316 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Alabama, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04853316 about?
NCT04853316 is a clinical study titled "Asymptomatic SARS-CoV-2 Detection in Children". The primary objective of this study is quantify the transmission risk posted by SARS-CoV-2 in pre/asymptomatic infected children in order to inform the public health response to the COVID-19 pandemic.
What is the current status of trial NCT04853316?
This trial is currently completed. The enrollment target is 372 participants. The study started on 2021-01-31. Estimated completion is 2022-08-22.
What conditions does trial NCT04853316 study?
This clinical trial studies the following conditions: Covid19, SARS-CoV-2.
Who is sponsoring clinical trial NCT04853316?
This trial is sponsored by University of Calgary, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04853316 being conducted?
This trial has 5 study locations across Alabama, California, Massachusetts, Texas, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.